Elevation Oncology LLC
ELEV · NASDAQ
Price unavailable right now.
No price history for this range.
EPS: actual vs estimate
Beat the estimate in 4 of the last 8 quarters, by 21.7% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q1 FY25 | -$0.1966 | -$0.24 | −22.1% |
| Q4 FY24 | -$0.2276 | -$0.18 | +20.9% |
| Q3 FY24 | -$0.2028 | -$0.22 | −8.5% |
| Q2 FY24 | -$0.2282 | -$0.18 | +21.1% |
| Q1 FY24 | -$0.2062 | -$0.23 | −11.5% |
| Q4 FY23 | -$0.2421 | -$0.19 | +21.5% |
| Q3 FY23 | -$0.3264 | -$0.25 | +23.4% |
| Q2 FY23 | -$0.3281 | -$0.37 | −12.8% |
Earnings calls
- Special Call - Elevation Oncology, Inc.
- Cowen 43rd Annual Healthcare Conference
- 41st Annual J.P. Morgan Healthcare Conference
- Special Call - Elevation Oncology, Inc.
- Special Call - Elevation Oncology, Inc.
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.